Starling Amaal J, Vargas Bert B
Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA,
Curr Pain Headache Rep. 2015 Oct;19(10):49. doi: 10.1007/s11916-015-0521-0.
Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.
慢性偏头痛是一种使人衰弱的疾病,影响全球2%的人口,并产生重大的社会和经济影响。慢性偏头痛管理的基石包括准确诊断、患者教育、合并症的治疗以及选择适当的、基于证据的急性和预防性治疗方案。虽然用对发作性偏头痛有效的预防性药物治疗慢性偏头痛很常见,但有一些治疗选择有治疗慢性偏头痛有效的具体证据。目前,A型肉毒毒素注射是美国食品药品监督管理局(FDA)批准的唯一用于慢性偏头痛的预防性治疗方法。包括枕神经和眶上神经刺激在内的一些非药物治疗选择已显示出有望成为无法耐受口服药物或口服药物无法缓解的患者的有效预防方法,但仍需要更多研究。